John G. Ullman & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $738K | Sell |
|
|||||
|
2025
Q1 | $4.08M | Buy |
|
|||||
|
2024
Q4 | $2.36M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.07M | Sell |
|
|||||
|
2022
Q3 | $3.02M | Sell |
|
|||||
|
2022
Q2 | $2.63M | Buy |
|
|||||
|
2022
Q1 | $559K | Hold |
|
|||||
|
2021
Q4 | $505K | Hold |
|
|||||
|
2021
Q3 | $484K | Hold |
|
|||||
|
2021
Q2 | $447K | Hold |
|
|||||
|
2021
Q1 | $379K | Hold |
|
|||||
|
2020
Q4 | $386K | Hold |
|
|||||
|
2020
Q3 | $448K | Hold |
|
|||||
|
2020
Q2 | $499K | Hold |
|
|||||
|
2020
Q1 | $391K | Hold |
|
|||||
|
2019
Q4 | $300K | Sell |
|
|||||
|
2019
Q3 | $229K | Sell |
|
|||||
|
2019
Q2 | $282K | Hold |
|
|||||
|
2019
Q1 | $370K | Hold |
|
|||||
|
2018
Q4 | $336K | Hold |
|
|||||
|
2018
Q3 | $364K | Hold |
|
|||||
|
2018
Q2 | $310K | Hold |
|
|||||
|
2018
Q1 | $310K | Hold |
|
|||||
|
2017
Q4 | $338K | Hold |
|
|||||
|
2017
Q3 | $402K | Hold |
|
|||||
|
2017
Q2 | $442K | Sell |
|
|||||
|
2017
Q1 | $368K | Hold |
|
|||||
|
2016
Q4 | $349K | Buy |
|
|||||
|
2016
Q3 | $362K | Sell |
|
|||||
|
2016
Q2 | $349K | Hold |
|
|||||
|
2016
Q1 | $360K | Sell |
|
|||||
|
2015
Q4 | $565K | Sell |
|
|||||
|
2015
Q3 | $489K | Sell |
|
|||||
|
2015
Q2 | $592K | Sell |
|
|||||
|
2015
Q1 | $565K | Hold |
|
|||||
|
2014
Q4 | $513K | Sell |
|
|||||
|
2014
Q3 | $456K | Hold |
|
|||||
|
2014
Q2 | $357K | Hold |
|
|||||
|
2014
Q1 | $380K | Sell |
|
|||||
|
2013
Q4 | $376K | Sell |
|
|||||
|
2013
Q3 | $490K | Sell |
|
|||||
|
2013
Q2 | $363K | Buy |
|